{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T07:21:47Z","timestamp":1758266507775,"version":"3.37.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T00:00:00Z","timestamp":1560384000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T00:00:00Z","timestamp":1560384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100006728","name":"Parents and Professors' Association, Kitasato University School of Medicine","doi-asserted-by":"publisher","award":["1"],"award-info":[{"award-number":["1"]}],"id":[{"id":"10.13039\/501100006728","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s10147-019-01486-y","type":"journal-article","created":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T15:02:47Z","timestamp":1560438167000},"page":"1412-1418","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Impact of histologic variants on the oncological outcomes of patients with upper urinary tract cancers treated with radical surgery: a multi-institutional retrospective study"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6071-218X","authenticated-orcid":false,"given":"Yasukiyo","family":"Murakami","sequence":"first","affiliation":[]},{"given":"Kazumasa","family":"Matsumoto","sequence":"additional","affiliation":[]},{"given":"Masaomi","family":"Ikeda","sequence":"additional","affiliation":[]},{"given":"Takahiro","family":"Hirayama","sequence":"additional","affiliation":[]},{"given":"Takuji","family":"Utsunomiya","sequence":"additional","affiliation":[]},{"given":"Dai","family":"Koguchi","sequence":"additional","affiliation":[]},{"given":"Daisuke","family":"Matsuda","sequence":"additional","affiliation":[]},{"given":"Norihiko","family":"Okuno","sequence":"additional","affiliation":[]},{"given":"Yoshinori","family":"Taoka","sequence":"additional","affiliation":[]},{"given":"Akira","family":"Irie","sequence":"additional","affiliation":[]},{"given":"Masatsugu","family":"Iwamura","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2019,6,13]]},"reference":[{"issue":"5","key":"1486_CR1","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/S0022-5347(05)67019-X","volume":"164","author":"JJ Munoz","year":"2000","unstructured":"Munoz JJ, Ellison LM (2000) Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. J Urol 164(5):1523\u20131525","journal-title":"J Urol"},{"issue":"1","key":"1486_CR2","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.eururo.2017.07.036","volume":"73","author":"M Roupr\u00eat","year":"2018","unstructured":"Roupr\u00eat M, Babjuk M, Comp\u00e9rat et al (2018) European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 update. Eur Urol 73(1):111\u2013122","journal-title":"Eur Urol"},{"issue":"4","key":"1486_CR3","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.eururo.2008.01.006","volume":"53","author":"R Zigeuner","year":"2008","unstructured":"Zigeuner R, Pummer K (2008) Urothelial carcinoma of the upper urinary tract: surgical approach and prognostic factors. Eur Urol 53(4):720\u2013731","journal-title":"Eur Urol"},{"issue":"6","key":"1486_CR4","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1111\/j.1464-410X.2009.08821.x","volume":"105","author":"M Waldert","year":"2010","unstructured":"Waldert M, Karakiewicz PI, Raman JD et al (2010) A delay in radical nephroureterectomy can lead to upstaging. BJU Int 105(6):812\u2013817","journal-title":"BJU Int"},{"issue":"4","key":"1486_CR5","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.eururo.2009.11.035","volume":"57","author":"R Zigeuner","year":"2010","unstructured":"Zigeuner R, Shariat SF, Margulis V et al (2010) Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract. Eur Urol 57(4):575\u2013581","journal-title":"Eur Urol"},{"issue":"2","key":"1486_CR6","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s10147-014-0721-3","volume":"20","author":"S Sakano","year":"2015","unstructured":"Sakano S, Matsuyama H, Kamiryo Y et al (2015) Impact of variant histology on disease aggressiveness and outcome after nephroureterectomy in Japanese patients with upper tract urothelial carcinoma. Int J Clin Oncol 20(2):362\u2013368","journal-title":"Int J Clin Oncol"},{"issue":"3","key":"1486_CR7","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.urology.2005.09.010","volume":"67","author":"JE Busby","year":"2006","unstructured":"Busby JE, Brown GA, Tamboli P et al (2006) Upper urinary tract tumors with nontransitional histology: a single-center experience. Urology 67(3):518\u2013523","journal-title":"Urology"},{"issue":"3","key":"1486_CR8","doi-asserted-by":"publisher","first-page":"357","DOI":"10.4103\/0974-7796.184885","volume":"8","author":"P Chaudhary","year":"2016","unstructured":"Chaudhary P, Agarwal R, Srinivasan S et al (2016) Primary adenocarcinoma of ureter: a rare histopathological variant. Urol Ann 8(3):357\u2013359","journal-title":"Urol Ann"},{"issue":"6","key":"1486_CR9","doi-asserted-by":"publisher","first-page":"385","DOI":"10.4111\/kju.2014.55.6.385","volume":"55","author":"M Nadeem","year":"2014","unstructured":"Nadeem M, Ather MH (2014) Impact of histopathological variant on the outcome of patients treated by radical cystectomy. Korean J Urol 55(6):385\u2013389","journal-title":"Korean J Urol"},{"issue":"5","key":"1486_CR10","doi-asserted-by":"publisher","first-page":"692","DOI":"10.21037\/tau.2016.06.13","volume":"5","author":"Y Klaile","year":"2016","unstructured":"Klaile Y, Schlack K, Boegemann M et al (2016) Variant histology in bladder cancer: how it should change the management in non-muscle invasive and muscle invasive disease? Transl Androl Urol 5(5):692\u2013701","journal-title":"Transl Androl Urol"},{"key":"1486_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-3656-4","volume-title":"AJCC cancer staging manual","author":"FL Greene","year":"2002","unstructured":"Greene FL, Page DL, Fleming ID et al (2002) AJCC cancer staging manual, 6th edn. Springer, New York","edition":"6"},{"issue":"12","key":"1486_CR12","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1097\/00000478-199812000-00001","volume":"22","author":"JI Epstein","year":"1998","unstructured":"Epstein JI, Amin MB, Reuter VR et al (1998) The World Health Organization\/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 22(12):1435\u20131448","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"1486_CR13","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.7314\/APJCP.2015.16.8.3223","volume":"16","author":"K Matsumoto","year":"2015","unstructured":"Matsumoto K, Hirayama T, Kobayashi K et al (2015) Laparoscopic retroperitoneal nephroureterectomy is a safe and adherent modality for obese patients with upper urinary tract urothelial carcinoma. Asian Pac J Cancer Prev 16(8):3223\u20133227","journal-title":"Asian Pac J Cancer Prev"},{"issue":"3","key":"1486_CR14","doi-asserted-by":"publisher","first-page":"e669","DOI":"10.1016\/j.clgc.2017.10.014","volume":"16","author":"M Ikeda","year":"2018","unstructured":"Ikeda M, Matsumoto K, Hirayama T et al (2018) Selected high-risk patients with upper tract urothelial carcinoma treated with radical nephroureterectomy for adjuvant chemotherapy: a multi-institutional retrospective study. Clin Genitourin Cancer 16(3):e669\u2013e675","journal-title":"Clin Genitourin Cancer"},{"issue":"5","key":"1486_CR15","doi-asserted-by":"publisher","first-page":"204.e9","DOI":"10.1016\/j.urolonc.2015.02.010","volume":"33","author":"Y Shibing","year":"2015","unstructured":"Shibing Y, Turun S, Qiang W et al (2015) Effect of concomitant variant histology on the prognosis of patients with upper urinary tract urothelial carcinoma after radical nephroureterectomy. Urol Oncol 33(5):204.e9\u2013e16","journal-title":"Urol Oncol"},{"issue":"6","key":"1486_CR16","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s00345-015-1715-0","volume":"34","author":"Q Tang","year":"2015","unstructured":"Tang Q, Xiong G, Li X et al (2015) The prognostic impact of squamous and glandular differentiation for upper tract urothelial carcinoma patients after radical nephroureterectomy. World J Urol 34(6):871\u2013877","journal-title":"World J Urol"},{"issue":"2","key":"1486_CR17","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.juro.2012.04.009","volume":"188","author":"M Rink","year":"2012","unstructured":"Rink M, Robinson BD, Green DA et al (2012) Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma. J Urol 188(2):398\u2013404","journal-title":"J Urol"},{"issue":"6","key":"1486_CR18","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.urolonc.2016.12.006","volume":"35","author":"M Moschini","year":"2017","unstructured":"Moschini M, Dell'Oglio P, Luciano' R et al (2017) Incidence and effect of variant histology on oncological outcomes in patients with bladder cancer treated with radical cystectomy. Urol Oncol 35(6):335\u2013341","journal-title":"Urol Oncol"},{"issue":"7","key":"1486_CR19","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1016\/j.urolonc.2017.02.010","volume":"35","author":"JK Kim","year":"2017","unstructured":"Kim JK, Moon KC et al (2017) Variant histology as a significant predictor of survival after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma. Urol Oncol 35(7):e9\u2013458.e15","journal-title":"Urol Oncol"},{"issue":"3","key":"1486_CR20","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.eururo.2014.03.003","volume":"66","author":"JJ Leow","year":"2014","unstructured":"Leow JJ, Martin-Doyle W et al (2014) A systematic review and meta-analysis of adjuvant and neoadjuvant chemotherapy for upper tract urothelial carcinoma. Eur Urol 66(3):529\u2013541","journal-title":"Eur Urol"},{"issue":"2","key":"1486_CR21","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/bju.14020","volume":"121","author":"A Necchi","year":"2018","unstructured":"Necchi A, Lo Vullo S, Mariani L et al (2018) Adjuvant chemotherapy after radical nephroureterectomy does not improve survival in patients with upper tract urothelial carcinoma: a joint study by the European Association of Urology-Young Academic Urologists and the Upper Tract Urothelial Carcinoma Collaboration. BJU Int 121(2):252\u2013259","journal-title":"BJU Int"},{"issue":"1","key":"1486_CR22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.urology.2006.01.053","volume":"68","author":"C Kwak","year":"2006","unstructured":"Kwak C, Lee SE, Jeong IG, Ku JH (2006) Adjuvant systemic chemotherapy in the treatment of patients with invasive transitional cell carcinoma of the upper urinary tract. Urology 68(1):53\u201357","journal-title":"Urology"},{"issue":"1","key":"1486_CR23","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12894-017-0305-4","volume":"17","author":"K Fujita","year":"2017","unstructured":"Fujita K, Taneishi K, Inamoto T et al (2017) Adjuvant chemotherapy improves survival of patients with high-risk upper urinary tract urothelial carcinoma: a propensity score-matched analysis. BMC Urol 17(1):110","journal-title":"BMC Urol"},{"issue":"1","key":"1486_CR24","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/bju.12801","volume":"116","author":"I Lucca","year":"2015","unstructured":"Lucca I, Kassouf W, Kapoor A et al (2015) The role of adjuvant chemotherapy for lymph node-positive upper tract urothelial carcinoma following radical nephroureterectomy: a retrospective study. BJU Int 116(1):72\u201378","journal-title":"BJU Int"},{"issue":"11","key":"1486_CR25","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1016\/S1470-2045(16)30496-X","volume":"17","author":"P Sharma","year":"2016","unstructured":"Sharma P, Callahan MK, Bono P et al (2016) Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, phase 1\/2 trial. Lancet Oncol 17(11):1590\u20131598","journal-title":"Lancet Oncol"},{"issue":"15","key":"1486_CR26","doi-asserted-by":"publisher","first-page":"4501","DOI":"10.1200\/JCO.2016.34.15_suppl.4501","volume":"34","author":"P Sharma","year":"2016","unstructured":"Sharma P, Bono P, Kim JW et al (2016) Efficacy and safety of nivolumab monotherapy in metastatic urothelial cancer (mUC): results from the phase I\/II CheckMate 032 study. J Clin Oncol 34(15):4501","journal-title":"J Clin Oncol"},{"key":"1486_CR27","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1056\/NEJMoa1613683","volume":"376","author":"J Bellmunt","year":"2017","unstructured":"Bellmunt J, de Wit R, Vaughn DJ et al (2017) Pembrolizumab as second-line therapy for advanced urothelial carcinoma. N Engl J Med 376:1015\u20131026","journal-title":"N Engl J Med"},{"unstructured":"Necchi A. An open label, single-arm, phase 2 study of neoadjuvant pembrolizumab (MK-3475) before cystectomy for patients with muscle-invasive urothelial bladder cancer. \n                    https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02736266","key":"1486_CR28"},{"unstructured":"Bristol-Myers Squibb. A phase 3 randomized, double-blind, multi-center study of adjuvant nivolumab versus placebo in subjects with high risk invasive urothelial carcinoma (CheckMate 274: CHECKpoint Pathway and nivoluMAb Clinical Trial Evaluation 274). \n                    https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02632409","key":"1486_CR29"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-019-01486-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10147-019-01486-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-019-01486-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T23:43:14Z","timestamp":1591918994000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10147-019-01486-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,13]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["1486"],"URL":"https:\/\/doi.org\/10.1007\/s10147-019-01486-y","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"type":"print","value":"1341-9625"},{"type":"electronic","value":"1437-7772"}],"subject":[],"published":{"date-parts":[[2019,6,13]]},"assertion":[{"value":"19 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}